AXL — Drug Target
All drugs that target AXL — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 2 pipeline (1)
- CAB-AXL-ADC · BioAtla, Inc. · Antibody-drug conjugate (ADC) · Oncology
CAB-AXL-ADC is an antibody-drug conjugate that targets AXL-expressing cancer cells and delivers cytotoxic payload upon binding.